Previous Article | Next Article ![]()
Journal of Virology, October 2000, p. 9507-9514, Vol. 74, No. 20
Department of Biology, Johns Hopkins
University, Baltimore, Maryland 21218,1 and
EMBL, D-69117 Heidelberg, Germany2
Received 2 May 2000/Accepted 11 July 2000
Rous sarcoma virus (RSV), a simple retrovirus, needs to export
unspliced viral RNA from the nucleus to the cytoplasm, circumventing the host cell restriction on cytoplasmic expression of
intron-containing RNA. The cytoplasmic accumulation of full-length
viral RNA is promoted by two cis-acting direct repeat (DR)
elements that flank the src gene; at least one copy of the
DR sequence is necessary for viral replication. We show here that the
DR mediates export of a reporter construct from the nucleus, suggesting
it is a constitutive transport element (CTE). In contrast, human
immunodeficiency virus type 1 (HIV-1) and other complex retroviruses
encode accessory proteins, Rev or Rex, which promote export of
incompletely spliced viral transcripts. This RNA export pathway is CRM1
dependent and can be blocked by the cytotoxic agent leptomycin B. We
show here that DR-mediated export is CRM1 independent, suggesting that
RSV uses a different export pathway from that of HIV-1 and other
complex retroviruses. The simian retroviruses have a CTE which
interacts with the cellular Tap export protein. However, we were unable to detect binding of the RSV DR RNA to Tap, suggesting it may use a
different export pathway from that of the simian retroviruses. These
data suggest that the RSV DR element uses a novel nucleocytoplasmic export pathway.
A defining feature of eukaryotic
cells is their division into nucleoplasm and cytoplasm. One consequence
of the nuclear membrane is the partitioning of unspliced pre-mRNA away
from the cytoplasm where spliced mRNA is translated. Cellular mRNAs are
exported from the nucleus only after processing is completed (10,
26, 27). Retroviruses use cellular factors for RNA transcription, capping, splicing, and polyadenylation; however, they require unspliced
RNA to be present in the cytoplasm both for translation of
gag and pol genes and for packaging into virions
(11). The export of these incompletely processed RNAs is
dependent on cis-acting elements within the RNA (reviewed in
references 3, 12, and 21).
The complex retroviruses encode accessory proteins that interact with
viral cis-acting RNA elements. The human immunodeficiency virus type 1 (HIV-1) protein Rev binds directly to the Rev response element (RRE) within the env gene to accumulate a
cytoplasmic population of unspliced and partially spliced RNA species
(reviewed in reference 12). Xenopus
oocyte injection experiments have shown that Rev mediates export of
RRE-containing RNA and that it can inhibit export of cellular 5S rRNA
and spliceosomal U snRNA (15). Rev contains a nuclear export
signal (15) that binds the cellular protein, chromosomal
region maintenance protein 1 (CRM1), or exportin-1, which is linked to
the GTP-Ran transport cofactor (16). CRM1 binds to
nucleoporins, including Nup214/Can, thus targeting the complex to the
nuclear pore (17). The cytotoxin leptomycin B (LMB) inhibits
Rev-mediated export by binding CRM1 and preventing assembly of the
Rev-CRM1-Ran-GTP complex (16, 25, 44). Other complex
retroviruses, including human T-cell leukemia virus type 1 (HTLV-1),
equine infectious anemia virus (EIAV), feline immunodeficiency virus
(FIV), and the human endogenous retrovirus HTDV/HERV-K also encode
nuclear export signal (NES)-containing proteins that interact with
CRM1, and their export is blocked by LMB (7, 28, 35).
In contrast, simple retroviruses do not encode accessory proteins; they
rely upon the interaction of cellular factors with their
cis-acting elements for export of their unspliced RNA
species (reviewed in references 3, 12, and
21). The simian type D retroviruses Mason-Pfizer
monkey virus (MPMV) and SRV-1 contain a cis-acting
constitutive transport element (CTE) that is necessary for unspliced
RNA export (9, 14, 46). The CTE appears to form a stem-loop
structure which is highly conserved (13, 42). CTE-containing
intron lariats are exported from Xenopus oocyte nuclei and
can compete for export with some cellular mRNAs (36, 37).
The export of MPMV RNA is LMB independent (35), suggesting it does not use the CRM1 export pathway. Recently, the hepatitis B
virus posttranscriptional regulatory element has also been shown to be
resistant to LMB treatment (35); however, its cofactors have
not been identified.
Several different cellular cofactors have been proposed for the closely
related MPMV and SRV-1 CTEs. These CTEs bind the cellular protein Tap
specifically in vitro, and this interaction promotes CTE-mediated
export in Xenopus oocytes and in transfected quail cells
(6, 20, 24). The C-terminal domain of Tap interacts with the
nuclear pore complex (2). Interestingly, Tap is homologous to Mex67p, an mRNA export factor in yeast (38). RNA helicase A (RHA) has also been reported to bind specifically to the MPMV CTE and
to colocalize with it in infected cells (43).
The Rous sarcoma virus (RSV) direct repeat (DR) sequences each contain
approximately 100 nucleotides (nt) and flank the src gene in
RSV. In the Prague C (PrC) strain of RSV, these two sequences are
located at nt 6897 and nt 8791 and have been termed DR1 and DR2,
respectively (33). One copy of either of these DR sequences has been shown to be sufficient for cytoplasmic RNA accumulation (1, 33). The closely related avian leukosis virus (ALV) has a single copy of this sequence in the 3' untranslated region of the
genome (45). Mutations within this element have been shown in our laboratory to suppress viral replication and to markedly reduce
the levels of full-length viral RNA in the cytoplasm (32, 33). We have also observed a slightly decreased half-life of unspliced viral RNAs lacking both DR elements (33). However, others have seen a smaller decrease in cytoplasmic RNA levels with
their DR mutants and have proposed that a major function of the DR
element involves packaging of virion RNA (1, 41). Impairment
of Gag protein processing was also observed with DR mutants, leading to
the proposal that the DR has a role in virion assembly, possibly by
affecting the cytoplasmic localization of the RNA (31, 39,
40).
In an attempt to resolve the controversy over whether or not the DR
element functions as a CTE, we chose to assay it in a nonviral context.
This removes complications due to different rates of viral replication,
as well as possible effects of the DR element on packaging of RNA into
virions or on Gag protein processing. We also wanted to be able to
assay the DR activities in various cell types, irrespective of the
ability of RSV to replicate in them. Several different laboratories
have used different methods of cell fractionation, perhaps contributing
to differences in determination of the relative levels of cytoplasmic
viral RNA (1, 33, 40, 41). To resolve this, we wanted to
test the possible role of the DR as a CTE, by using a method that did
not require cell fractionation. We chose to use the pCMV128
chloramphenicol acetyltransferase (CAT) reporter construct, because it
has been widely used to assay RNA export in other systems (22, 23, 30, 43). Using this reporter construct, we have observed that the
DR can mediate HIV-1-CAT unspliced mRNA export. Furthermore, DR
mutations that inhibit viral replication (32) similarly
inhibited export of unspliced CAT mRNA. These experiments suggest that
at least one function of the DR element is that of a CTE.
We next asked whether the RSV DR element uses the same export pathway
as either the HIV-1 Rev-RRE complex or the SRV CTE. We report that LMB,
an inhibitor of the CRM1 pathway for RNA export used by complex
retroviruses, did not inhibit DR-mediated export of a CAT reporter
construct. Furthermore, we were unable to detect binding of Tap to the
RSV DR RNA in a gel shift assay, suggesting its export pathway may
differ from that of the SRV CTE. Finally, we observed some activity of
the DR element in mammalian as well as in avian cells.
Plasmids.
pCMV128 and pCMVRev were obtained from Tom Hope.
pCMV128 was derived from pDM128 (22) by replacement of the
simian virus 40 (SV40) promoter with the CMV promoter (30).
The DR elements were inserted at a unique BamHI site
directly downstream of the CAT gene in pCMV128 (Fig. 1A). The DR
fragments inserted into pCMV128 were generated by PCR methods. The
primers used for the generation of DR2 and the DR2 point mutants were
5' 8770 GAGTGAGGATCCGCGTCCTGCGTTGCTCCG and 3' 8925 GAGTGAGGATCCCAGGGAAGACGCCATCAT. These primers were used with
viral DNA templates pPrC (wild-type Pr-C RSV) (33), pPrC-G8844C, and pPrC-G8863C (32). The DR1 construct was
generated with primers 5' 6863 GAGTGAGGATCCTAGAGCTCAGTTATAATA
and 3' 7037 AGTGAGGATCCATATTAAGACTACATTTTT and the
pPrC template.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Rous Sarcoma Virus DR Posttranscriptional Elements
Use a Novel RNA Export Pathway


![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Cell culture and DNA transfection. Secondary chicken embryo fibroblasts (CEFs) were cultured in medium 199 containing 2% tryptose phosphate, 1% calf serum, 1% heat-inactivated chick serum, and 1% antibiotic-antimycotic (all from Life Technologies). For CAT assays, a 6-cm-diameter dish of cells was cotransfected with 0.5 µg of the pCMV128 reporter construct and 0.25 µg of pGL3-control luciferase reporter construct (Promega) in medium 199 containing 200 µg of DEAE-dextran per ml. After 4 h, cells were subjected to a 10% dimethyl sulfoxide shock for 2 min; they were harvested 48 h later. For the LMB experiments, medium was removed 24 h after transfection and replaced with medium containing either 5 or 10 nM LMB (25), a kind gift from Minoru Yoshida. Cells were harvested 18 h after LMB addition. For preparation of nuclear and cytoplasmic RNA, 15-cm-diameter plates were transfected with 10 µg of pCMV128 constructs.
HeLa cells were cultured in Dulbecco's modified Eagle medium (DMEM) with 10% fetal calf serum and 1% antibiotic-antimycotic (all from Life Technologies). Cells were transfected with 7.0 µg of plasmid DNA per 10-cm-diameter dish by using Lipofectamine (Life Technologies) for 5 h. This mixture was removed and overlaid with fresh medium, and cells were harvested 48 h later.CAT assays. CAT activity was measured by the method of Gorman et al. (19). Acetylated and nonacetylated [14C]chloramphenicol (Amersham) products were resolved by thin-layer chromatography and quantified with an InstantImager (Packard). Luciferase assays to measure expression of the cotransfected pGL3-control plasmid were carried out on a Berthold luminometer. All CAT data shown are the average of at least three separate transfections and are normalized relative to the luciferase control.
RT assay. A reverse transcriptase (RT) assay was used to monitor viral replication as described previously (33). Cells were transfected with full-length viral constructs. Forty-eight hours later, medium was harvested from the cells. Viral particles were concentrated from 2 ml of medium by centrifugation for 2 h at 14,000 × g in a refrigerated centrifuge (Savant). The pellet was resuspended in RT buffer for assay.
RNA isolation and RNase protection assays. Total cellular RNA was harvested by using RNAzol B (Tel-Test) 48 h after transfection. Transcription of antisense riboprobes and RNase protection analysis were performed as previously described (4). The 128 riboprobe construct, which spans the 3' splice site, was a gift from Gordon Carmichael (23). The DNA template was linearized with EcoRI and transcribed with T3 RNA polymerase (Life Technologies). The riboprobe was hybridized to nuclear or cytoplasmic RNA fractions for 16 h at 55°C. RNase digestions utilized 10 µg of RNase A and 10 U of RNase T1 per ml (both from Calbiochem) and were carried out at 30°C for 1 h. Electrophoresis of protected RNA was on a 6% polyacrylamide gel containing 8 M urea, and quantitation of protected bands was carried out on an InstantImager (Packard).
Cell fractionation. Cytoplasmic and nuclear RNAs were isolated by a citric acid cell fractionation protocol described previously (5, 33). This is a stringent cell fractionation method that strips the outer nuclear membrane. As a control for the fractionation procedure, an aliquot of RNA from each fraction was electrophoresed on a 1.3% agarose gel in MOPS (morpholinepropanesulfonic acid) buffer (0.04 M MOPS, 10 mM sodium acetate, 1 mM EDTA [pH 7.0]) for 30 min at 100 V. Prior to loading, RNA samples were precipitated, resuspended in 2 µl of water, and mixed with 10 µl of loading buffer (1× MOPS, 50% formamide, 1/5 volume of 37% formaldehyde, and 5 µg of ethidium bromide). The samples were then heated for 10 min at 65°C and placed on ice prior to loading. This method allowed visualization of cellular rRNA and pre-rRNA, as well as tRNA and snRNA, in the subcellular fractions.
Electrophoretic mobility shift assay. Tap binding assays were performed with in vitro-transcribed 32P-labeled RSV DR2 RNA and SRV-1 CTE RNA. Tap protein was synthesized in a rabbit reticulocyte lysate, and the gel shift assays were carried out as described by Braun et al. (8).
| |
RESULTS |
|---|
|
|
|---|
The RSV DR sequence promotes nucleocytoplasmic RNA export. We showed previously that the mutation or deletion of both copies of the DR sequence in full-length viral constructs results in the inhibition of viral replication and a decrease in unspliced viral RNA accumulation in the cytoplasm (32, 33). However, we did not see a buildup of unspliced RNA in the nucleus with these viral mutants, so it was not clear whether the DR sequence promoted RNA export or stabilization (nuclear or cytoplasmic) or both. Our working hypothesis is that the DR mutants inhibit export of the viral unspliced RNA, leading to its splicing or degradation in the nucleus and reduced cytoplasmic accumulation. However, other investigators have proposed that the major role of the DR in viral replication involves packaging of virion RNA (1, 41) or virion assembly (39, 40). Since the assays for RNA export were based on quantitation of RNA levels in the nucleus and the cytoplasm after cell fractionation, it is possible that the differences observed are due to different methods of cell fractionation.
Thus, in this study, we used an assay that was independent of viral replication and also did not require cell fractionation to ask whether the block in viral replication observed with DR point mutations (32) correlates with a block in RNA export. The pCMV128 reporter construct was developed by Hope and colleagues to study nucleocytoplasmic RNA export (30). This construct differs from pDM128 (22) by replacement of the SV40 promoter with the CMV promoter (Fig. 1A). Like pDM128, it contains the CAT gene in the tat-rev intron of the HIV-1 env gene. We left the RRE intact because we found that its removal increased background levels of CAT expression in some cell types (data not shown). Since the tat-rev intron is inefficiently spliced due to suboptimal HIV-1 splice sites (34), both unspliced and spliced RNAs are generated in the nucleus. CAT protein synthesis requires the unspliced cat mRNA to be exported to the cytoplasm. This assay has been used to measure Rev-RRE-mediated RNA export (22), as well as MPMV CTE export (43). The DR1 and DR2 wild-type sequences and flanking sequences (RSV nt 6863 to 7037 and 8770 to 8925, respectively) and two DR2 point mutants were cloned into the pCMV128 construct downstream of the CAT gene as shown in Fig. 1A.
|
DR sequence promotes cytoplasmic accumulation of unspliced CAT
mRNA.
Since the CAT assay is a sensitive measure of enzymatic
activity that can be affected by factors other than RNA export, we also
analyzed the levels of nuclear and cytoplasmic RNAs resulting from
transfection with the pCMV128 constructs. Cells were fractionated by a
stringent citric acid fractionation method that strips the outer
nuclear membrane (5, 33). As a control for the fractionation procedure, we electrophoresed an aliquot of the RNA from each subcellular fraction on an agarose gel and stained it with ethidium bromide (Fig. 2B). We detected 45S
pre-rRNA only in the nuclear fractions and 28S and 18S rRNA only in the
cytoplasmic fraction. We also detected a large amount of tRNA in the
cytoplasm. Thus, the fractionation appeared to give good separation of
the nuclear and cytoplasmic RNA species.
|
RSV DR is active in mammalian cells.
We had originally
identified the RSV DR elements as having Rev-like activity by using an
HIV-1 gag-pol-RRE expression construct to measure Gag
protein expression in the absence of Rev (33). Using a
Western blot assay, we detected Gag protein expression in CEFs, but not
in COS cells. Conversely, we detected MPMV CTE activity in COS cells,
but not in CEFs, by this assay. Since the CMV128 CAT assay is more
sensitive than the HIV-1 Gag protein Western assay, we reexamined the
activity of the DR in mammalian cells (Fig.
3).
|
RSV DR uses a different export pathway from that of HIV-1.
Rev
acts to export RRE-containing RNA through the interaction of its
nuclear export signal (NES) with CRM1. CRM1 can be inhibited by LMB,
rendering it unable to bind the NES of Rev (18). LMB has
been shown to inhibit Rev-mediated export (16, 44). We asked
whether the RSV DR used the same export pathway as Rev. To this end,
the pCMV128 constructs described above were transfected into CEFs.
After 24 h, various doses of LMB were added, and the cells were
harvested 18 h later. We compared the effects of LMB on pCMV128
constructs cotransfected with Rev (Fig.
4A) and on the pCMV128DR constructs
in the absence of Rev (Fig. 4B).
|
RSV DR RNA does not bind Tap directly. As we have seen for RSV DR-mediated export (see Fig. 4B), SRV-1 or MPMPV CTE-mediated export is resistant to LMB, suggesting it does not bind CRM1 (25, 35). Since the SRV CTE has been shown to bind the cellular protein Tap and this interaction appears to be important for CTE function (6, 8, 20, 24), we asked whether the DR RNA might also bind the human Tap protein. To this end, we carried out gel shift assays comparing interactions between Tap and either the SRV-1 CTE RNA or the RSV DR RNA.
Figure 5 shows the results of an electrophoretic mobility shift assay using human Tap protein synthesized in a rabbit reticulocyte lysate. As a negative control, 32P-labeled SRV CTE RNA was incubated with reticulocyte lysate lacking Tap; this did not result in a gel shift (Fig. 5, lane 1). As a positive control, the SRV-1 CTE RNA was incubated with reticulocyte lysate containing Tap and competed with either the M36 mutant CTE RNA (lane 2) or with various amounts of wild-type SRV-1 CTE RNA (lanes 3 to 5). Two shifted bands were observed, which may be due to the binding of one or two copies of Tap per CTE RNA. While binding of 32P-labeled SRV CTE RNA to Tap was not inhibited by cold M36 RNA (lane 2), increasing amounts of wild-type SRV-1 CTE RNA effectively competed for Tap binding (lanes 3 to 5). In contrast, incubation with 1 µg of RSV DR2 RNA did not affect Tap binding (lane 6), so no competition was seen between the SRV-1 CTE and the RSV DR RNA. As a further test of a possible interaction between Tap and the DR RNA, labeled DR2 RNA was used in a gel shift assay (lane 8). No gel shift bands were observed, suggesting there is no detectable interaction between Tap and the DR RNA under these stringent conditions. This result suggests that the DR sequence may use a different export pathway from that of the SRV CTE. However, this experiment does not rule out the possibility that Tap might interact with the DR RNA under less stringent conditions or in the presence of a putative bridging factor.
|
| |
DISCUSSION |
|---|
|
|
|---|
Simple retrovirus dependence on cellular factors for the unorthodox transport of incompletely spliced mRNAs makes these viruses a useful tool for the study of nucleocytoplasmic export of RNA. Previous work on retroviral RNA export has shown that overexpression of the HIV-1 Rev NES domain inhibits export of both cellular 5S rRNA and U snRNA, suggesting that these pathways share common factors (15). Furthermore, the export factor CRM1 is the cellular mediator between Rev and the nuclear pore (16, 17). Similarly, the MPMV or SRV-1 CTE utilizes an mRNA export pathway and interacts with the cellular export protein Tap (2, 6, 8, 20, 24, 36, 37). RHA has also been implicated in the SRV CTE export pathway (43).
In this paper, we propose that the avian retroviral DR uses a third
viral export pathway. We have found that DR-mediated export is
resistant to LMB, suggesting it does not require CRM1. Thus, RSV
appears to use a different RNA export pathway from that of HIV-1 and
the other complex retroviruses, HTLV-1, EIAV, FIV, and HERV-K (7,
28, 35). Furthermore, we have been unable to demonstrate binding
of the DR RNA to Tap in vitro. While we have not ruled out the
possibility of weak or indirect interactions between Tap and the DR
RNA, our data suggest that the RSV RNA export pathway differs from that
of the simian type D retroviruses. We conclude that the avian DR
element uses a novel export pathway, as depicted in the model in Fig.
6. It will be of great interest to
determine factors involved in the export of the DR system, because this
may teach us more about cellular nucleocytoplasmic export mechanisms.
|
We have shown here that the DR elements are active in the pCMV128 reporter system, commonly used as an assay for RNA export (22, 23, 45). Furthermore, point mutations that impair RSV replication were found to impair CAT activity to similar extents. In the reporter system, we observed an accumulation of unspliced RNA in the nucleus with DR mutants, further supporting its involvement in RNA export. This suggests that one function of the DR element is the promotion of unspliced RNA export. However, we have previously shown that full-length RNAs lacking both DR elements have about a twofold shorter half-life than wild-type RNAs (34). Thus, a role for stabilization of RSV unspliced RNA by the presence of the DR elements is also likely. The instability observed in the absence of both DR elements may be a result of a block in export, because similar results were observed with HIV-1 when Rev was mutated (29). In addition, others have proposed a role for the DR in RNA packaging (1, 41) and cytoplasmic localization of the RNA, which may be related to virion assembly (31, 39, 40). Thus, it seems likely that this element may play more than one role in the viral life cycle. In fact, if there is a coupling between RNA nuclear export and its cytoplasmic localization, stabilization, and translation, it would make sense for one cis-acting element to be involved in all of these functions. However, different cellular factors may interact with the DR to promote these different functions.
In this study, we have observed DR-induced CAT activity in HeLa cells, demonstrating its ability to function in a mammalian cell line. In contrast, we previously failed to detect DR-mediated export in COS cells using a less sensitive Western assay (33). Constructs bearing mutations in the DR2 element were less active than the wild type in HeLa cells, but to a lesser degree than in avian cells. This could be due to the presence of additional binding factors in HeLa cells. The DR elements have also been shown to be inactive in Xenopus oocytes where Rev-RRE and the MPMV CTE are both active. Conversely, the RSV DR is active in quail cells, where the MPMV CTE has been reported to be inactive (24).
After the manuscript for this article had been initially submitted, Yang and Cullen (45) reported the presence of a CTE in the single DR sequence of RAV-2 ALV. This sequence is closely related to that of RSV DR1 and DR2 (33). Using the pDM128 assay, CAT activity was observed in both quail and mammalian cell lines (45). This ALV CTE activity was shown to be CRM1 independent with truncated CAN nucleoporin as a competitive inhibitor of CRM1 (45), thus confirming our experiments with LMB and the RSV DR element.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by Public Health Service grant RO1CA48746 from the National Cancer Institute. R.E.P. and R.A.O. were supported in part by NIH predoctoral training grant 52T32G07231.
We thank Minoru Yoshida, Tom Hope, Barbara Felber, Gordon Carmichael, and Flossie Wong-Staal for reagents and Jennifer Rahmandar and Utz Fischer for help with experiments.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Biology, Johns Hopkins University, 3400 N. Charles St., Baltimore, MD 21218. Phone: (410) 516-7289. Fax: (410) 516-7292. E-mail: KLB{at}jhu.edu.
Present address: Purdue Biopharma L.P., Princeton, NJ 08540.
Present address: NCI-Frederick Cancer Research and Development
Center, Frederick, MD 21702.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Aschoff, J. M.,
D. Foster, and J. M. Coffin.
1999.
Point mutations in the avian sarcoma/leukosis virus 3' untranslated region result in a packaging defect.
J. Virol.
73:7421-7429 |
| 2. | Bachi, A., I. C. Braun, J. P. Rodrigues, N. Pante, K. Ribbeck, C. von Kobbe, U. Kutay, M. D. Wilm, M. Carmo-Fonseca, and E. Izaurralde. 2000. The C-terminal domain of TAP interacts with the nuclear pore complex and promotes export of specific CTE-bearing RNA substrates. RNA 6:136-158[Abstract]. |
| 3. | Banks, J., K. Beemon, and M. Linial. 1997. RNA regulatory elements in the genomes of simple retroviruses. Semin. Virol. 8:194-204[CrossRef]. |
| 4. |
Barker, G. F., and K. Beemon.
1991.
Nonsense codons within the Rous sarcoma virus gag gene decrease the stability of unspliced viral RNA.
Mol. Cell. Biol.
11:2760-2768 |
| 5. |
Barker, G. F., and K. Beemon.
1994.
Rous sarcoma virus RNA stability requires an open reading frame in the gag gene and sequences downstream of the gag-pol junction.
Mol. Cell. Biol.
14:1986-1996 |
| 6. |
Bear, J.,
W. Tan,
A. S. Zolotukhin,
C. Tabernero,
E. A. Hudson, and B. K. Felber.
1999.
Identification of novel import and export signals of human TAP, the protein that binds to the constitutive transport element of the type D retrovirus mRNAs.
Mol. Cell. Biol.
19:6306-6317 |
| 7. |
Bogerd, H. P.,
A. Echarri,
T. M. Ross, and B. R. Cullen.
1998.
Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1.
J. Virol.
72:8627-8635 |
| 8. | Braun, I. C., E. Rohrbach, C. Schmitt, and E. Izaurralde. 1999. TAP binds to the constitutive transport element (CTE) through a novel RNA-binding motif that is sufficient to promote CTE-dependent RNA export from the nucleus. EMBO J. 18:1953-1965[CrossRef][Medline]. |
| 9. |
Bray, M.,
S. Prasad,
J. W. Dubay,
E. Hunter,
K. T. Jeang,
D. Rekosh, and M. L. Hammarskjold.
1994.
A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent.
Proc. Natl. Acad. Sci. USA
91:1256-1260 |
| 10. | Chang, D. D., and P. A. Sharp. 1989. Regulation by HIV Rev depends upon recognition of splice sites. Cell 59:789-795[CrossRef][Medline]. |
| 11. | Coffin, J., S. Hughes, and H. Varmus. 1997. Retroviruses. Cold Spring Harbor Laboratory Press, Plainview, N.Y. |
| 12. | Cullen, B. R. 1998. Retroviruses as model systems for the study of nuclear RNA export pathways. Virology 249:203-210[CrossRef][Medline]. |
| 13. | Ernst, R. K., M. Bray, D. Rekosh, and M. L. Hammarskjold. 1997. Secondary structure and mutational analysis of the Mason-Pfizer monkey virus RNA constitutive transport element. RNA 3:210-222[Abstract]. |
| 14. | Ernst, R. K., M. Bray, D. Rekosh, and M. L. Hammarskjöld. 1997. A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA. Mol. Cell. Biol. 17:135-144[Abstract]. |
| 15. | Fischer, U., J. Huber, W. C. Boelens, I. W. Mattaj, and R. Luhrmann. 1995. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-483[CrossRef][Medline]. |
| 16. | Fornerod, M., M. Ohno, M. Yoshida, and I. W. Mattaj. 1997. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051-1060[CrossRef][Medline]. |
| 17. | Fornerod, M., J. van Deursen, S. van Baal, A. Reynolds, D. Davis, K. G. Murti, J. Fransen, and G. Grosveld. 1997. The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component, Nup88. EMBO J. 16:807-816[CrossRef][Medline]. |
| 18. | Fukuda, M., S. Asano, T. Nakamura, M. Adachi, M. Yoshida, M. Yanagida, and E. Nishida. 1997. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390:308-311[CrossRef][Medline]. |
| 19. |
Gorman, C. M.,
L. F. Moffat, and B. H. Howard.
1982.
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Mol. Cell. Biol.
2:1044-1051 |
| 20. | Gruter, P., C. Tabernero, C. von Kobbe, C. Schmitt, C. Saavedra, A. Bachi, M. Wilm, B. K. Felber, and E. Izaurralde. 1998. TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus. Mol. Cell 1:649-659[CrossRef][Medline]. |
| 21. | Hammarskjold, M. L. 1997. Regulation of retroviral RNA export. Semin. Cell Dev. Biol. 8:83-90[CrossRef][Medline]. |
| 22. |
Hope, T. J.,
X. J. Huang,
D. McDonald, and T. G. Parslow.
1990.
Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif.
Proc. Natl. Acad. Sci. USA
87:7787-7791 |
| 23. |
Huang, Y., and G. G. Carmichael.
1997.
The mouse histone H2a gene contains a small element that facilitates cytoplasmic accumulation of intronless gene transcripts and of unspliced HIV-1-related mRNAs.
Proc. Natl. Acad. Sci. USA
94:10104-10109 |
| 24. |
Kang, Y., and B. R. Cullen.
1999.
The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences.
Genes Dev.
13:1126-1139 |
| 25. | Kudo, N., B. Wolff, T. Sekimoto, E. P. Schreiner, Y. Yoneda, M. Yanagida, S. Horinouchi, and M. Yoshida. 1998. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242:540-547[CrossRef][Medline]. |
| 26. | Legrain, P., and M. Rosbash. 1989. Some cis- and trans-acting mutants for splicing target pre-mRNA to the cytoplasm. Cell 57:573-583[CrossRef][Medline]. |
| 27. |
Luo, M.-J., and R. Reed.
1999.
Splicing is required for rapid and efficient mRNA export in metazoans.
Proc. Natl. Acad. Sci. USA
96:14937-14942 |
| 28. |
Magin, C.,
R. Löwer, and J. Löwer.
1999.
cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-K.
J. Virol.
73:9496-9507 |
| 29. |
Malim, M. H., and B. R. Cullen.
1993.
Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes.
Mol. Cell. Biol.
13:6180-6189 |
| 30. |
McDonald, D.,
T. J. Hope, and T. G. Parslow.
1992.
Posttranscriptional regulation by the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex proteins through a heterologous RNA binding site.
J. Virol.
66:7232-7238 |
| 31. |
Nasioulas, G.,
S. H. Hughes,
B. K. Felber, and J. M. Whitcomb.
1995.
Production of avian leukosis virus particles in mammalian cells can be mediated by the interaction of the human immunodeficiency virus protein Rev and the Rev-responsive element.
Proc. Natl. Acad. Sci. USA
92:11940-11944 |
| 32. |
Ogert, R. A., and K. L. Beemon.
1998.
Mutational analysis of the Rous sarcoma virus DR posttranscriptional control element.
J. Virol.
72:3407-3411 |
| 33. | Ogert, R. A., L. H. Lee, and K. L. Beemon. 1996. Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. J. Virol. 70:3834-3843[Abstract]. |
| 34. | O'Reilly, M. M., M. T. McNally, and K. L. Beemon. 1995. Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology 213:373-385[CrossRef][Medline]. |
| 35. |
Otero, G. C.,
M. E. Harris,
J. E. Donello, and T. J. Hope.
1998.
Leptomycin B inhibits equine infectious anemia virus Rev and feline immunodeficiency virus Rev function but not the function of the hepatitis B virus posttranscriptional regulatory element.
J. Virol.
72:7593-7597 |
| 36. | Pasquinelli, A. E., R. K. Ernst, E. Lund, C. Grimm, M. L. Zapp, D. Rekosh, M. L. Hammarskjold, and J. E. Dahlberg. 1997. The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J. 16:7500-7510[CrossRef][Medline]. |
| 37. | Saavedra, C., B. Felber, and E. Izaurralde. 1997. The simian retrovirus-1 constitutive transport element, unlike the HIV-1 RRE, uses factors required for cellular mRNA export. Curr. Biol. 7:619-628[CrossRef][Medline]. |
| 38. | Segref, A., K. Sharma, V. Doye, A. Hellwig, J. Huber, R. Luhrmann, and E. Hurt. 1997. Mex67p, a novel factor for nuclear mRNA export, binds to both poly(A)+ RNA and nuclear pores. EMBO J. 16:3256-3271[CrossRef][Medline]. |
| 39. | Simpson, S. B., W. Guo, S. C. Winistorfer, R. C. Craven, and C. M. Stoltzfus. 1998. The upstream, direct repeat sequence of Prague A Rous sarcoma virus is deficient in mediating efficient Gag assembly and particle release. Virology 247:86-96[CrossRef][Medline]. |
| 40. | Simpson, S. B., L. Zhang, R. C. Craven, and C. M. Stoltzfus. 1997. Rous sarcoma virus direct repeat cis elements exert effects at several points in the virus life cycle. J. Virol. 71:9150-9156[Abstract]. |
| 41. |
Sorge, J.,
W. Ricci, and S. H. Hughes.
1983.
cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus.
J. Virol.
48:667-675 |
| 42. | Tabernero, C., A. S. Zolotukhin, A. Valentin, G. N. Pavlakis, and B. K. Felber. 1996. The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function. J. Virol. 70:5998-6011[Abstract]. |
| 43. |
Tang, H.,
G. M. Gaietta,
W. H. Fischer,
M. H. Ellisman, and F. Wong-Staal.
1997.
A cellular cofactor for the constitutive transport element of type D retrovirus.
Science
276:1412-1415 |
| 44. | Wolff, B., J. J. Sanglier, and Y. Wang. 1997. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem. Biol. 4:139-147[CrossRef][Medline]. |
| 45. | Yang, J., and B. Cullen. 1999. Structural and functional analysis of the avian leukemia virus constitutive transport element. RNA 5:1645-1655[Abstract]. |
| 46. |
Zolotukhin, A. S.,
A. Valentin,
G. N. Pavlakis, and B. K. Felber.
1994.
Continuous propagation of RRE( ) and Rev( )RRE( ) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes.
J. Virol.
68:7944-7952 |
| 47. |
Zuker, M.
1989.
On finding all suboptimal foldings of an RNA molecule.
Science
244:48-52 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|